Laxxon Medical announced its attending the 42nd Annual J.P. Morgan Healthcare Conference, the industry's largest healthcare symposium.

Discover how 3D printing is revolutionizing drug manufacturing, enhancing patient experiences, and paving the way for personalized medicine.

What is first-pass metabolism, and how is it affecting drug effectiveness? 3D printing is revolutionizing the pharmaceutical solutions.

Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company's inaugural globalization venture.

Laxxon Medical announced its participation in the 29th annual BIO-Europe Convention, taking place November 6-8, 2023, in Munich, Germany.

Unlocking the Potential of 3D Printing in Precision Medicine: Learn how patient-specific medications can revolutionize healthcare.

Why Are Generic Pharmaceutical Drugs Important? We break down what generic pharmaceutical drugs are, and why they are so important.

Explore the transformative potential of 3D printing in personalized medicine, revolutionized drug delivery, and optimized effects.

Why is 3D printing for medication so revolutionary? We look into the benefits and how exactly the makeup of the pills we take works.

Technology has come a long way in the last decade and is rapidly changing the world of medicine. Digital innovations in healthcare...

Understandably, people would be concerned about what 3D-printed pharmaceuticals are and how the whole process works. After all, most...

Drug solubility refers to the properties within a drug (solute), allowing it to dissolve in a particular solution (solvent), which in...

3D printing isn’t new to anyone, but many of its applications are only now being fully realized. For example, while you may be aware of...

Laxxon Medical to Participate in 2023 BIO International Convention

Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts

What are the regulatory challenges faced by the 3D printing of pharmaceuticals, and how do we overcome them?

Hovione and Laxxon Medical have partnered for the cGMP production of 3D Screen Printed pharmaceutical applications.

CSO Achim Schneeberger speaks on the development of Laxxon's Levodopa project and the process of Laxxon's technology.

Laxxon Medical is looking at how improving patient experiences for women should be a priority for all medical service providers.

Exploring Patient Safety, Compliance & 3D Screen Printing with Laxxon COO Klaus Kühne